Alliancaude e Participacoes (BSP:AALR3) Notes Receivable: R$0 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:AALR3 Allianca Saude e Participacoes SA BSP:AALR3
49 GF Score
Price R$3.20
GF Value R$9.40
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Alliancaude e Participacoes Notes Receivable?

Alliancaude e Participacoes BSP:AALR3 -1.54% 49 Notes Receivable is R$0 Mil as of Sep. 2025. GuruFocus rates BSP:AALR3 with a GF Score™ of 49/100 and a GF Value™ of R$9.40 (Possible Value Trap). The stock has 4 warning signs investors should review.

Alliancaude e Participacoes's Notes Receivable for the quarter that ended in Sep. 2025 was R$0 Mil.

Alliancaude e Participacoes Notes Receivable Related Terms

Alliancaude e Participacoes Notes Receivable Historical Data

* Premium members only.

The historical data trend for Alliancaude e Participacoes's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alliancaude e Participacoes Notes Receivable Chart

Alliancaude e Participacoes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alliancaude e Participacoes Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BSP:AALR3
49GF Score
Allianca Saude e Participacoes SA BSP:AALR3
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alliancaude e Participacoes Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of R$0 Mil mean?
Alliancaude e Participacoes (BSP:AALR3) has a Notes Receivable of R$0 Mil as of Sep. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Alliancaude e Participacoes and its competitors.
Is Alliancaude e Participacoes' Notes Receivable too high?
Alliancaude e Participacoes' current Notes Receivable is R$0 Mil. Overall, Alliancaude e Participacoes has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Alliancaude e Participacoes' Notes Receivable compare to TMO and DHR?
Alliancaude e Participacoes' Notes Receivable of R$0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Alliancaude e Participacoes and its competitors. Alliancaude e Participacoes's current Notes Receivable is R$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alliancaude e Participacoes stock overvalued right now?
Based on GuruFocus' analysis, Alliancaude e Participacoes (BSP:AALR3) is currently considered Possible Value Trap. The stock's GF Value™ is R$9.40, compared to a current price of R$3.20 — trading 66% below its estimated fair value. The current Notes Receivable is R$0 Mil. Alliancaude e Participacoes' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Alliancaude e Participacoes (BSP:AALR3), the current Notes Receivable is R$0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alliancaude e Participacoes (BSP:AALR3) Overvalued in 2026?

Based on GuruFocus' analysis, Alliancaude e Participacoes stock appears to be undervalued. The current stock price of R$3.20 is trading 66% below its estimated GF Value™ of R$9.40. GuruFocus considers Alliancaude e Participacoes to be Possible Value Trap.

Key valuation signals for BSP:AALR3:

  • Notes Receivable: R$0 Mil
  • GF Value™: R$9.40 vs. price of R$3.20 (66% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the BSP:AALR3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alliancaude e Participacoes Business Description

Address Rua Marselhesa, no. 500, 7th floor, Andar Vila Mariana, Sao Paulo, SP, BRA, 04020-060
Allianca Saude e Participacoes SA formerly Centro de Imagem Diagnosticos SA - Alliar is a diagnostic imaging company consisting of MRI machines, CT scanners and ultrasound machines. Its products include diagnostic medicine, diagnostic imaging and clinical analysis. The company is also engaged in the import of medical and hospital equipment, diagnosis kits, and related goods; Providing health consulting, advisory, courses and lectures.
49GF Score

Get the complete analysis for BSP:AALR3

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$3.20
Price
R$9.40
GF Value